These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34850571)

  • 1. In silico design, chemical synthesis and biological screening of novel 4-(1H)-pyridone-based antimalarial agents.
    Audu O; Stander A; Ajani O; Egieyeh S; October N
    Chem Biol Drug Des; 2022 May; 99(5):674-687. PubMed ID: 34850571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1.
    Capper MJ; O'Neill PM; Fisher N; Strange RW; Moss D; Ward SA; Berry NG; Lawrenson AS; Hasnain SS; Biagini GA; Antonyuk SV
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):755-60. PubMed ID: 25564664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone-3-diarylethers: a new class of antimalarial drug.
    Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
    Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
    J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities.
    Monastyrskyi A; Kyle DE; Manetsch R
    Curr Top Med Chem; 2014; 14(14):1693-705. PubMed ID: 25116582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Ubiquinol-Reduction (Q
    Amporndanai K; Pinthong N; O'Neill PM; Hong WD; Amewu RK; Pidathala C; Berry NG; Leung SC; Ward SA; Biagini GA; Hasnain SS; Antonyuk SV
    Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazole based Furanone Hybrids as Novel Antimalarial: A Combined Experimental, Pharmacological and Computational Study.
    Choudhary D; Rani I; Monga J; Goyal R; Husain A; Garg P; Khokra SL
    Cent Nerv Syst Agents Med Chem; 2022; 22(1):39-56. PubMed ID: 35232355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical QSAR and Docking Simulation of 4-Pyridone Derivatives for Their Antimalarial Activity.
    Flores-Sumoza M; Alcázar JJ; Márquez E; Mora JR; Lezama J; Puello E
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antimalarial 4-pyridones with improved physico-chemical properties.
    Bueno JM; Manzano P; García MC; Chicharro J; Puente M; Lorenzo M; García A; Ferrer S; Gómez RM; Fraile MT; Lavandera JL; Fiandor JM; Vidal J; Herreros E; Gargallo-Viola D
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5214-8. PubMed ID: 21824778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A score years' update in the synthesis and biological evaluation of medicinally important 2-pyridones.
    Sangwan S; Yadav N; Kumar R; Chauhan S; Dhanda V; Walia P; Duhan A
    Eur J Med Chem; 2022 Mar; 232():114199. PubMed ID: 35219150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicomponent reaction to design antimalarial pyridyl-indole derivatives: Synthesis, biological activities and molecular docking.
    Elshemy HAH; Zaki MA; Mohamed EI; Khan SI; Lamie PF
    Bioorg Chem; 2020 Apr; 97():103673. PubMed ID: 32106041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
    Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
    Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
    SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial quinolones: synthesis, potency, and mechanistic studies.
    Winter RW; Kelly JX; Smilkstein MJ; Dodean R; Hinrichs D; Riscoe MK
    Exp Parasitol; 2008 Apr; 118(4):487-97. PubMed ID: 18082162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of antimalarial drug research with special reference to application of QSAR models.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.